期刊文献+

P53蛋白在卵巢上皮肿瘤组织中的表达及意义 被引量:6

EXPRESSION OF PROTEIN P53 IN EPITHELIAL OVARIAN TUMORS AND ITS SIGNIFICANCE
在线阅读 下载PDF
导出
摘要 目的探讨P53蛋白在卵巢上皮肿瘤组织中的表达及意义。方法应用免疫组织化学方法分别检测83例卵巢上皮肿瘤病人P53蛋白的表达,分析其与病理类型、细胞分化程度及临床分期的关系。结果卵巢上皮肿瘤恶性组P53蛋白阳性表达率明显高于交界组及良性组(χ2=3.857、21.776,P<0.01);恶性组中P53蛋白阳性表达率与组织类型无关(χ2=0.005,P>0.05);G1、G2级阳性表达率显著低于G3级(χ2=5.154、7.540,P<0.05);临床Ⅰ、Ⅱ期阳性表达率低于Ⅲ、Ⅳ期(χ2=5.236,P<0.05);P53蛋白阳性病人5年生存率显著低于P53蛋白阴性的病人(χ2=4.919,P<0.05)。结论P53蛋白表达的检测对卵巢上皮肿瘤良、恶性的鉴别及卵巢上皮性癌预后的评估有一定的意义。 Objective To investigate the significance of protein P53 expression in the ovarian epithelial tumor. Methods Immunohistochemical method was applied to detect theP53 expression in 83 patients ovarian epithelial tumor. The relationship of P53 expression with pathological type, cell differentiation, and clinical staging was analyzed. Results P53 expression in malignant group was significantly higher than those in borderline and in benign group (x^2=3.857.21.776; P〈0.01). TheP53 expression in malignant group was irrelevant to histological type (x^2 =0. 005, P〉0.05); it was evidently less expressed in G2 and G2 groups than in G3, group (x^2=5. 154.7. 540,P〈0. 05 ), its expression in stages Ⅰ and Ⅱ was less than that of stages Ⅲ and Ⅳ (x^=5.236,P〈0.05). The 5-yearsurvival rate in patients with P53 positive was less than those with P53 negative (x^2= 4. 919, P〈0.05). Conclusion The detection of P53 expression is of certain significance in differential diagnosis between malignant and nonmalignant epithelial ovarian tumor, and in assessment of the prognosis of ovarian carcinoma.
出处 《青岛大学医学院学报》 CAS 2006年第3期255-256,共2页 Acta Academiae Medicinae Qingdao Universitatis
关键词 卵巢肿瘤 蛋白质P53 免疫组织化学 ovarian neoplasms protein P53 immunohistochemistry
作者简介 王雪鹤(1975-),女,在读硕士
  • 相关文献

参考文献8

  • 1SHERIDAN E,SILCOCKS P,SMITH J,et al.p53 mutation in a series of epithelial ovarian cancers from the U.K,and its prognostic significance[J].Eur J Cancer,1994,30(11):1701-1706.
  • 2ELTABBAKH G I I,BELINSON J L,KENNEDY A W,et al.p53 over expression is not an independent prognostic factor for patients with primary ovarian epithelial cancer[J].Cancer,1997,80(5):892-895.
  • 3HOLLSTEIN M,SIDRANSKY D,VOGELSTEIN J,et al.p53 mutations in human cancers[J].Science,1991,49(3):253-256.
  • 4尤宗兵,郭燕燕,曹泽毅.野生型p53基因cDNA转染对卵巢癌细胞系SKOV-3生物学行为的影响[J].中华妇产科杂志,1997,32(12):715-717. 被引量:7
  • 5RIGHETTI S C,DELLA T G,PILOTTI S,et al.A comparative study of p53 gene mutation protein accumulation and response to cisplatin based chemotherapy in advanced ovarian carcinoma[J].Cancer Res,1995,5(12):1345-1348.
  • 6LEVINE A J,MOMAND J,FINLAY A.The p53 tumor suppressor gene[J].Nature (Lond),1991,351:452-456.
  • 7VANMEIR E G,POLVERNI P J,CHAZIN V R,et al.Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cell[J].Nat Genet,1994,8:171-176.
  • 8孙衍增,牛兆山.P53蛋白和增殖细胞核抗原在前列腺癌中的表达及意义[J].青岛大学医学院学报,2001,37(4):309-311. 被引量:6

二级参考文献4

  • 1黄杰雄.增殖细胞核抗原的研究进展[J].国外医学(生理病理科学与临床分册),1994,14(1):9-11. 被引量:94
  • 2尤宗兵,中华妇产科杂志,1996年,31卷,660页
  • 3鄂征,组织培养和分子细胞学技术,1995年,157页
  • 4卢圣栋,现代分子生物学实验技术,1993年,403页

共引文献11

同被引文献68

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部